FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine and concerns antagonising the hedgehog signalling pathway in a cell by using the methods of treating cancer with a cyclopamide derivative of general formula (1).
EFFECT: developing the new method of treating cancer.
34 cl, 5 tbl, 35 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLOPAMINE ANALOGUES | 2007 |
|
RU2486194C2 |
CYCLOPAMINE ANALOGUES AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2403256C2 |
MAGL INHIBITORS | 2017 |
|
RU2754536C1 |
PYRIDYL-PIPERIDINE ANTAGONISTS OF OREXIN RECEPTORS | 2008 |
|
RU2470021C2 |
SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2781639C2 |
IMIDAZOPYRROLOPYRINE DERIVATIVES USEFUL FOR TREATING DISEASES CAUSED BY ABNORMAL ACTIVITY OF PROTEIN KINASES JAK1, JAK3 OR SYK | 2010 |
|
RU2711869C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
IAP INHIBITORS | 2005 |
|
RU2401840C2 |
TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
DIAZONIUM AMIDE ANALOGUES | 2012 |
|
RU2608308C2 |
Authors
Dates
2013-09-20—Published
2007-12-27—Filed